Showing results (271-280 of 299) with videos related to

Sort By:
Pageof 30
Kidney International|February 19, 2010
Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)Zoltán H Endre, Robert J Walker, John W Pickering, et al.
International Journal of Cardiology|April 21, 2024
Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in Western and Asian patients with acute breathlessnessJanice Chew-Harris, Chris Frampton, Charlotte Greer, et al.
Frontiers in Cardiovascular Medicine|May 1, 2023
An integrated signature of extracellular matrix proteins and a diastolic function imaging parameter predicts post-MI long-term outcomesHiromi W L Koh, Anna P Pilbrow, Sock Hwee Tan, et al.
BMJ Open|June 13, 2024
Protocol for Improving Care by FAster risk-STratification through use of high sensitivity point-of-care troponin in patients presenting with possible acute coronary syndrome in the EmeRgency department (ICare-FASTER): a stepped-wedge cluster randomised quality improvement initiativeJohn W Pickering, Gerard Devlin, Richard Body, et al.
Kidney International|February 11, 2011
Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal functionZoltán H Endre, John W Pickering, Robert J Walker, et al.
Clinical Chemistry|December 2, 2016
Immediate Rule-Out of Acute Myocardial Infarction Using Electrocardiogram and Baseline High-Sensitivity Troponin IJohannes Tobias Neumann, Nils Arne Sörensen, Francisco Ojeda, et al.
Clinical Chemistry|May 16, 2018
Detectable High-Sensitivity Cardiac Troponin within the Population Reference Interval Conveys High 5-Year Cardiovascular Risk: An Observational StudyMartin P Than, Sally J Aldous, Richard W Troughton, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 PneumoniaZelalem Temesgen, Mariam Assi, Paschalis Vergidis, et al.
European Heart Journal Open|April 3, 2025
Insulin-like growth factor binding protein-3 (IGFBP-3): a biomarker of coronary artery disease induced myocardial ischaemiaJacqui A Lee, Jessika Wise, Sara D Raudsepp, et al.
Clinical Chemistry|May 19, 2017
Direct Comparison of 2 Rule-Out Strategies for Acute Myocardial Infarction: 2-h Accelerated Diagnostic Protocol vs 2-h AlgorithmKarin Wildi, Louise Cullen, Raphael Twerenbold, et al.
Pageof 30